IDEXX Laboratories Announces Executive Vice President Johnny Powers to Retire in May 2016

WESTBROOK, Maine, Feb. 12, 2016 /PRNewswire/ -- IDEXX Laboratories, Inc. (IDXX) announced today that Johnny D. Powers, Ph.D., Executive Vice President, will be retiring from the Company in May 2016 and has stepped down from his current position effective February 8, 2016. Dr. Powers has been Executive Vice President since 2012 and has been employed by the Company since 2009.

"IDEXX has benefited substantially from Johnny's many contributions during his tenure. Most notably, his key role in developing IDEXX's global leadership position in our reference lab business, reflecting his focus on product innovation, creative commercial strategies, strategic lab acquisitions, geographic expansion, and better commercial alignment across the entire Companion Animal Group (CAG) organization. During his tenure, IDEXX delivered several new breakthrough reference lab products and services to the veterinary market, including SDMA, and brought our reference lab quality and service to world-class levels. Johnny's leadership has also been critical in completing several important business transformations over the last several years, including our fully-implemented all-direct strategy for US CAG Diagnostics," said Jonathan Ayers, the Company's Chairman and Chief Executive Officer. "We are fortunate to have a deep and talented leadership team to assist in the transition of Johnny's accountabilities. We thank Johnny and wish him all the best in his retirement."

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 6,000 people and offers products to customers in over 175 countries.

Contact: Ed Garber, Director, Investor Relations, 1-207-556-8155

Logo -

To view the original version on PR Newswire, visit:

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…